AL-38583 Ophthalmic Solution

· Alcon Research

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AL-38583 Ophthalmic Solution, covering 2014-07-17 to 2014-07-17. Get the full timeline:

Most recent: Clinical Trial Update: AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation [Phase 2]